Bidding war?So, for those of you who haven't been paying attention, Denali is floundering at $33 with their less than favorable data. Their sp is a far cry from their high of $90, but it's also ridiculously higher than bioasis’ $0.25 sp.
So, who is going to be the major player that is going to get drugs into the brain? Obviously, my bet is bioasis and Xb3.
So, do you all think that only one pharma will make a bid for bioasis when the time comes? My opinion has always been that if Xb3 works, there would likely be multiple competing offers. It’s simply too valuable.
So?